Raju Raval - Publications

Affiliations: 
2001-2004 University of Oxford, Oxford, United Kingdom 

9/58 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2010 Biswas S, Troy H, Leek R, Chung YL, Li JL, Raval RR, Turley H, Gatter K, Pezzella F, Griffiths JR, Stubbs M, Harris AL. Effects of HIF-1alpha and HIF2alpha on Growth and Metabolism of Clear-Cell Renal Cell Carcinoma 786-0 Xenografts. Journal of Oncology. 2010: 757908. PMID 20652061 DOI: 10.1155/2010/757908  0.559
2007 Lau KW, Tian YM, Raval RR, Ratcliffe PJ, Pugh CW. Target gene selectivity of hypoxia-inducible factor-alpha in renal cancer cells is conveyed by post-DNA-binding mechanisms. British Journal of Cancer. 96: 1284-92. PMID 17387348 DOI: 10.1038/sj.bjc.6603675  0.667
2007 Abdulrahman M, Maina EN, Morris MR, Zatyka M, Raval RR, Banks RE, Wiesener MS, Richards FM, Johnson CM, Latif F, Maher ER. Identification of novel VHL targets that are associated with the development of renal cell carcinoma. Oncogene. 26: 1661-72. PMID 17001320 DOI: 10.1038/sj.onc.1209932  0.367
2006 Esteban MA, Tran MG, Harten SK, Hill P, Castellanos MC, Chandra A, Raval R, O'brien TS, Maxwell PH. Regulation of E-cadherin expression by VHL and hypoxia-inducible factor. Cancer Research. 66: 3567-75. PMID 16585181 DOI: 10.1158/0008-5472.Can-05-2670  0.638
2005 Raval RR, Lau KW, Tran MG, Sowter HM, Mandriota SJ, Li JL, Pugh CW, Maxwell PH, Harris AL, Ratcliffe PJ. Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma. Molecular and Cellular Biology. 25: 5675-86. PMID 15964822 DOI: 10.1128/Mcb.25.13.5675-5686.2005  0.73
2005 Maina EN, Morris MR, Zatyka M, Raval RR, Banks RE, Richards FM, Johnson CM, Maher ER. Identification of novel VHL target genes and relationship to hypoxic response pathways. Oncogene. 24: 4549-58. PMID 15824735 DOI: 10.1038/sj.onc.1208649  0.364
2004 Appelhoff RJ, Tian YM, Raval RR, Turley H, Harris AL, Pugh CW, Ratcliffe PJ, Gleadle JM. Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor. The Journal of Biological Chemistry. 279: 38458-65. PMID 15247232 DOI: 10.1074/Jbc.M406026200  0.777
2003 Sowter HM, Raval RR, Moore JW, Ratcliffe PJ, Harris AL. Predominant role of hypoxia-inducible transcription factor (Hif)-1alpha versus Hif-2alpha in regulation of the transcriptional response to hypoxia. Cancer Research. 63: 6130-4. PMID 14559790  0.78
2003 Knowles HJ, Raval RR, Harris AL, Ratcliffe PJ. Effect of ascorbate on the activity of hypoxia-inducible factor in cancer cells. Cancer Research. 63: 1764-8. PMID 12702559  0.737
Low-probability matches (unlikely to be authored by this person)
2022 Kalathoor S, Rajendran S, Canella A, Raval R, Cripe TP, Mardis ER, Rajappa P. Myeloid cell heterogeneity in the tumor microenvironment and therapeutic implications for childhood central nervous system (CNS) tumors. Journal of Neuroimmunology. 374: 578009. PMID 36508930 DOI: 10.1016/j.jneuroim.2022.578009  0.264
2022 Matsui JK, Perlow HK, Ritter AR, Upadhyay R, Raval RR, Thomas EM, Beyer SJ, Pillainayagam C, Goranovich J, Ong S, Giglio P, Palmer JD. Small Molecules and Immunotherapy Agents for Enhancing Radiotherapy in Glioblastoma. Biomedicines. 10. PMID 35885067 DOI: 10.3390/biomedicines10071763  0.226
2014 Raval RR, Sharabi AB, Walker AJ, Drake CG, Sharma P. Tumor immunology and cancer immunotherapy: summary of the 2013 SITC primer. Journal For Immunotherapy of Cancer. 2: 14. PMID 24883190 DOI: 10.1186/2051-1426-2-14  0.184
2015 Ni X, Zhang Y, Zennami K, Castanares M, Mukherjee A, Raval RR, Zhou H, DeWEese TL, Lupold SE. Systemic administration and targeted radiosensitization via chemically synthetic aptamer-siRNA chimeras in human tumor xenografts. Molecular Cancer Therapeutics. PMID 26438155 DOI: 10.1158/1535-7163.Mct-15-0291-T  0.176
2021 Dibs K, Prasad RN, Madan K, Liu K, Jiang W, Ghose J, Blakaj DM, Palmer JD, Kobalka P, Prevedello DM, Raval RR. Cerebellopontine angle ependymoma presenting as isolated hearing loss in an elderly patient: A case report and literature review. Surgical Neurology International. 12: 572. PMID 34877058 DOI: 10.25259/SNI_781_2021  0.17
2021 Beyer S, Sebastian NT, Prasad RN, Chu J, Liu K, Madan K, Jiang W, Ghose J, Blakaj DM, Palmer JD, Eltobgy M, Otero J, Elder JB, Raval RR. Malignant ossifying fibromyxoid tumor of the brain treated with post-operative fractionated stereotactic radiation therapy: A case report and literature review. Surgical Neurology International. 12: 588. PMID 34992905 DOI: 10.25259/SNI_827_2021  0.167
2021 Alnahhas I, Rayi A, Palmer JD, Raval R, Folefac E, Ong S, Giglio P, Puduvalli V. The role of VEGF receptor inhibitors in preventing cerebral radiation necrosis: a retrospective cohort study. Neuro-Oncology Practice. 8: 75-80. PMID 33664972 DOI: 10.1093/nop/npaa067  0.157
2023 Lehrer EJ, Kowalchuk RO, Gurewitz J, Bernstein K, Kondziolka D, Niranjan A, Wei Z, Lunsford LD, Fakhoury KR, Rusthoven CG, Mathieu D, Trudel C, Malouff TD, Ruiz-Garcia H, Bonney P, ... ... Raval RR, et al. Concurrent administration of immune checkpoint inhibitors and single fraction stereotactic radiosurgery in patients with non-small cell lung cancer, melanoma, and renal cell carcinoma brain metastases is not associated with an increased risk of radiation necrosis over non-concurrent treatment: An international multicenter study of 657 patients. International Journal of Radiation Oncology, Biology, Physics. PMID 36690161 DOI: 10.1016/j.ijrobp.2023.01.017  0.156
2016 Hedayati M, Haffner MC, Coulter J, Raval RR, Zhang Y, Zhou H, Mian O, Knight EJ, Dalrymple S, Isaacs JT, Santos A, Hales RK, Razavi N, Nelson WG, Yegnasubramanian S, et al. Androgen deprivation followed by acute androgen stimulation selectively sensitizes AR-positive prostate cancer cells to ionizing radiation. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26831716 DOI: 10.1158/1078-0432.Ccr-15-1147  0.14
2022 Upadhyay R, Yadav D, Venkatesulu BP, Singh R, Baliga S, Raval RR, Lazow MA, Salloum R, Fouladi M, Mardis ER, Zaorsky NG, Trifiletti DM, Paulino AC, Palmer JD. Risk of secondary malignant neoplasms in children following proton therapy vs. photon therapy for primary CNS tumors: A systematic review and meta-analysis. Frontiers in Oncology. 12: 893855. PMID 36033525 DOI: 10.3389/fonc.2022.893855  0.122
2014 Khattab M, Raval R, Zhang Y, Regter S, Hedayati M, Banerjee S, Zhou H, Ferraris D, Alt J, Rojas C, Slusher B, Pomper M, DeWeese T. PSMA-Targeted Low Molecular Weight Urea-siRNA Conjugates for Targeted Knockdown of DNA-PK and Radiosensitization of Prostate Cancer Cell Lines International Journal of Radiation Oncology*Biology*Physics. 90: S798-S799. DOI: 10.1016/J.Ijrobp.2014.05.2306  0.108
2023 Lehrer EJ, Khosla AA, Ozair A, Gurewitz J, Bernstein K, Kondziolka D, Niranjan A, Wei Z, Lunsford LD, Mathieu D, Trudel C, Deibert CP, Malouff TD, Ruiz-Garcia H, Peterson JL, ... ... Raval RR, et al. Immune checkpoint inhibition and single fraction stereotactic radiosurgery in brain metastases from non-small cell lung cancer: an international multicenter study of 395 patients. Journal of Neuro-Oncology. PMID 37889444 DOI: 10.1007/s11060-023-04413-4  0.108
2022 Dibs K, Blakaj DM, Prasad RN, Olausson A, Bourekas EC, Boulter D, Ayan AS, Cochran E, Marras WS, Mageswaran P, Thomas E, Lee H, Grecula J, Raval RR, Mendel E, et al. Spine Stereotactic Body Radiotherapy to Three or More Contiguous Vertebral Levels. Frontiers in Oncology. 12: 912804. PMID 35756685 DOI: 10.3389/fonc.2022.912804  0.095
2021 Odei B, Kahn J, Holliday EB, Diaz DA, Bello-Pardo E, Odei J, Bae J, Arnett A, Raval R, Mitchell D. Where Are the Women in Radiation Oncology? A Cross-Sectional Multi-Specialty Comparative Analysis. Advances in Radiation Oncology. 6: 100735. PMID 34278054 DOI: 10.1016/j.adro.2021.100735  0.094
2022 Perlow HK, Siedow M, Gokun Y, McElroy J, Matsui J, Zoller W, Beyer S, Arnett A, Blakaj D, Boulter D, Fritz J, Miller E, Raval R, Kleefisch C, Bovi J, et al. Ga-DOTATATE PET-based Radiation Contouring Creates More Precise Radiation Volumes for Meningioma Patients. International Journal of Radiation Oncology, Biology, Physics. PMID 35460804 DOI: 10.1016/j.ijrobp.2022.04.009  0.08
2021 Odei B, Das P, Pinnix C, Raval R, Holliday EB. Potential Implications of the New USMLE Step 1 Pass/Fail Format for Diversity Within Radiation Oncology. Advances in Radiation Oncology. 6: 100524. PMID 33490722 DOI: 10.1016/J.Adro.2020.07.001  0.075
2014 Starmer HM, Yang W, Raval R, Gourin CG, Richardson M, Kumar R, Jones B, McNutt T, Cheng Z, Cheng S, Quon H. Effect of gabapentin on swallowing during and after chemoradiation for oropharyngeal squamous cell cancer. Dysphagia. 29: 396-402. PMID 24633355 DOI: 10.1007/s00455-014-9521-1  0.074
2023 Perlow HK, Matsui JK, Ewing A, Cadieux C, Dibs K, Upadhyay R, Blakaj DM, Beyer SJ, Thomas EM, Grecula JC, Raval RR, Palmer JD. Volumetric Modulated Arc Therapy Craniospinal Irradiation Utilizing a Vertebral Body Sparing Approach: An Alternative Approach to Improve Access and Minimize Toxicity. Advances in Radiation Oncology. 9: 101424. PMID 38379893 DOI: 10.1016/j.adro.2023.101424  0.067
2022 Lehrer EJ, Ahluwalia MS, Gurewitz J, Bernstein K, Kondziolka D, Niranjan A, Wei Z, Lunsford LD, Fakhoury KR, Rusthoven CG, Mathieu D, Trudel C, Malouff TD, Ruiz-Garcia H, Bonney P, ... ... Raval RR, et al. Imaging-defined necrosis after treatment with single-fraction stereotactic radiosurgery and immune checkpoint inhibitors and its potential association with improved outcomes in patients with brain metastases: an international multicenter study of 697 patients. Journal of Neurosurgery. 1-10. PMID 36115055 DOI: 10.3171/2022.7.JNS22752  0.066
2023 Upadhyay R, Klamer BG, Perlow HK, White JR, Bazan JG, Jhawar SR, Blakaj DM, Grecula JC, Arnett A, Mestres-Villanueva MA, Healy EH, Thomas EM, Chakravarti A, Raval RR, Lustberg M, et al. Stereotactic Radiosurgery for Women Older than 65 with Breast Cancer Brain Metastases. Cancers. 16. PMID 38201564 DOI: 10.3390/cancers16010137  0.066
2022 Matsui JK, Perlow HK, Raj RK, Nalin AP, Lehrer EJ, Kotecha R, Trifiletti DM, McClelland S, Kendra K, Williams N, Owen DH, Presley CJ, Thomas EM, Beyer SJ, Blakaj DM, ... ... Raval RR, et al. Treatment of Brain Metastases: The Synergy of Radiotherapy and Immune Checkpoint Inhibitors. Biomedicines. 10. PMID 36140312 DOI: 10.3390/biomedicines10092211  0.062
2013 Raval R, Ni X, Zhang Y, Zhou H, Meeker A, Lupold S, DeWeese T. Systemic Delivery of Synthesized Aptamer-siRNA Chimeras Results in Prostate-Targeted Radiosensitization International Journal of Radiation Oncology*Biology*Physics. 87: S139. DOI: 10.1016/J.Ijrobp.2013.06.358  0.059
2022 Prasad RN, Kobalka PJ, Perlow HK, Prevedello DM, Blakaj DM, Raval RR, Palmer JD. Craniospinal irradiation for respiratory failure secondary to central nervous system Erdheim-Chester disease. Radiation Oncology Journal. 40: 162-168. PMID 35796119 DOI: 10.3857/roj.2021.01074  0.059
2020 Sebastian NT, Glenn C, Hughes R, Raval R, Chu J, DiCostanzo D, Bell EH, Grecula J, Arnett A, Gondal H, McGregor J, Elder JB, Lonser R, Chakravarti A, Trifiletti D, et al. Linear accelerator-based radiosurgery is associated with lower incidence of radionecrosis compared with gamma knife for treatment of multiple brain metastases. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 147: 136-143. PMID 32294607 DOI: 10.1016/J.Radonc.2020.03.024  0.055
2020 Alnahhas I, Alsawas M, Rayi A, Palmer JD, Raval R, Ong S, Giglio P, Murad HM, Puduvalli V. Characterizing benefit from temozolomide in MGMT promoter unmethylated and methylated glioblastoma: a systematic review and meta-analysis. Neuro-Oncology Advances. 2: vdaa082. PMID 33150334 DOI: 10.1093/noajnl/vdaa082  0.053
2022 Palmer JD, Perlow HK, Matsui JK, Ho C, Prasad RN, Liu K, Upadhyay R, Klamer B, Wang J, Damante M, Ghose J, Blakaj DM, Beyer S, Grecula J, Arnett A, ... ... Raval RR, et al. Fractionated pre-operative stereotactic radiotherapy for patients with brain metastases: a multi-institutional analysis. Journal of Neuro-Oncology. PMID 35751740 DOI: 10.1007/s11060-022-04073-w  0.05
2022 Lim M, Weller M, Idbaih A, Steinbach J, Finocchiaro G, Raval RR, Ansstas G, Baehring J, Taylor JW, Honnorat J, Petrecca K, De Vos F, Wick A, Sumrall A, Sahebjam S, et al. Phase 3 Trial of Chemoradiotherapy With Temozolomide Plus Nivolumab or Placebo for Newly Diagnosed Glioblastoma With Methylated MGMT Promoter. Neuro-Oncology. PMID 35511454 DOI: 10.1093/neuonc/noac116  0.049
2014 Raval RR, Frassica D, Thornton K, Meyer C, Ettinger DS, Frassica F, Weber K, Terezakis SA. Evaluating the Role of Interdigitated Neoadjuvant Chemotherapy and Radiation in the Management of High-Grade Soft-Tissue Sarcoma: The Johns Hopkins Experience. American Journal of Clinical Oncology. PMID 25268069 DOI: 10.1097/COC.0000000000000131  0.047
2020 Perlow HK, Dibs K, Liu K, Jiang W, Rajappa P, Blakaj DM, Palmer J, Raval RR. Whole-Brain Radiation Therapy Versus Stereotactic Radiosurgery for Cerebral Metastases. Neurosurgery Clinics of North America. 31: 565-573. PMID 32921352 DOI: 10.1016/J.Nec.2020.06.006  0.046
2022 Lehrer EJ, Gurewitz J, Bernstein K, Kondziolka D, Fakhoury KR, Rusthoven CG, Niranjan A, Wei Z, Lunsford LD, Malouff TD, Ruiz-Garcia H, Peterson JL, Bonney P, Hwang L, Yu C, ... ... Raval RR, et al. Concurrent Administration of Immune Checkpoint Inhibitors and Stereotactic Radiosurgery Is Well-Tolerated in Patients With Melanoma Brain Metastases: An International Multicenter Study of 203 Patients. Neurosurgery. PMID 36255215 DOI: 10.1227/neu.0000000000002127  0.045
2022 Dibs K, Palmer JD, Prasad RN, Olausson A, Bourekas EC, Boulter D, Ayan AS, Cochran E, Marras WS, Mageswaran P, Thomas E, Grecula J, Guiou M, Soghrati S, Tili E, ... Raval RR, et al. Feasibility, safety, and efficacy of circumferential spine stereotactic body radiotherapy. Frontiers in Oncology. 12: 912799. PMID 36505845 DOI: 10.3389/fonc.2022.912799  0.045
2023 Upadhyay R, Ayan AS, Jain S, Klamer BG, Perlow HK, Zoller W, Blakaj DM, Beyer S, Grecula J, Arnett A, Thomas E, Chakravarti A, Raval RR, Palmer JD. Dose/volume tolerance of the brain and predictors of radiation necrosis after three-fraction radiosurgery for brain metastases: A large single-institutional analysis. International Journal of Radiation Oncology, Biology, Physics. PMID 37574170 DOI: 10.1016/j.ijrobp.2023.07.040  0.043
2021 Alnahhas I, Alsawas M, Rayi A, Palmer JD, Raval R, Ong S, Giglio P, Murad MH, Puduvalli V. Erratum to: Characterizing Benefit from Temozolomide in MGMT Promoter Unmethylated and Methylated Glioblastoma: A Systematic Review and Meta-analysis. Neuro-Oncology Advances. 3: vdab095. PMID 34258581 DOI: 10.1093/noajnl/vdab095  0.041
2022 Palmer JD, Prasad RN, Fabian D, Wei L, Yildiz VO, Tan Y, Grecula J, Welliver M, Williams T, Elder JB, Raval R, Blakaj D, Haglund K, Bazan J, Kendra K, et al. Phase I study of trametinib in combination with whole brain radiation therapy for brain metastases. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 35367525 DOI: 10.1016/j.radonc.2022.03.016  0.04
2023 Damante MA, Gibbs D, Dibs K, Palmer JD, Raval R, Scharschmidt T, Chakravarti A, Bourekas E, Boulter D, Thomas E, Grecula J, Beyer S, Xu D, Nimjee S, Youssef P, et al. Neoadjuvant Arterial Embolization of Spine Metastases Associated With Improved Local Control in Patients Receiving Surgical Decompression and Stereotactic Body Radiotherapy. Neurosurgery. PMID 36861971 DOI: 10.1227/neu.0000000000002411  0.04
2020 Wolfe AR, Blakaj D, London N, Blakaj A, Klamer B, Pan J, Wakely P, Prevedello L, Bonomi M, Bhatt A, Raval R, Palmer J, Prevedello D, Gamez M, Carrau R. Clinical Outcomes and Multidisciplinary Patterns of Failure for Olfactory Neuroblastoma: The Ohio State Experience. Journal of Neurological Surgery. Part B, Skull Base. 81: 287-294. PMID 32500004 DOI: 10.1055/S-0039-1692479  0.038
2023 Dibs K, Facer B, Mageswaran P, Raval R, Thomas E, Gogineni E, Beyer S, Pan J, Klamer B, Ayan A, Bourekas E, Boulter D, Fetko N, Cochran E, Zoller I, et al. Vertebral Compression Fracture After Spine Stereotactic Body Radiotherapy: The Role of Vertebral Endplate Disruption. Neurosurgery. PMID 37902322 DOI: 10.1227/neu.0000000000002742  0.037
2023 Matsui JK, Perlow HK, Upadhyay R, McCalla A, Raval RR, Thomas EM, Blakaj DM, Beyer SJ, Palmer JD. Advances in Radiotherapy for Brain Metastases. Surgical Oncology Clinics of North America. 32: 569-586. PMID 37182993 DOI: 10.1016/j.soc.2023.02.007  0.037
2022 Perlow HK, Ho C, Matsui JK, Prasad RN, Klamer BG, Wang J, Damante M, Upadhyay R, Thomas E, Blakaj DM, Beyer S, Lonser R, Hardesty D, Raval RR, Prabhu R, et al. Comparing pre-operative versus post-operative single and multi-fraction stereotactic radiotherapy for patients with resectable brain metastases. Clinical and Translational Radiation Oncology. 38: 117-122. PMID 36420099 DOI: 10.1016/j.ctro.2022.11.004  0.037
2020 Odei B, Holliday EB, Jagsi R, Chino F, Schulmire C, Kudrimoti M, Chen AM, Raval R, Fabian D. Recruitment Challenges and Opportunities for Radiation Oncology Residency Programs During the 2020-2021 Virtual Residency Match. International Journal of Radiation Oncology, Biology, Physics. PMID 32798607 DOI: 10.1016/j.ijrobp.2020.08.024  0.037
2022 Perlow HK, Prasad RN, Yang M, Klamer B, Matsui J, Marrazzo L, Detti B, Scorsetti M, Clerici E, Arnett A, Beyer S, Ammirati M, Chakravarti A, Raval RR, Brown PD, et al. Accelerated hypofractionated radiation for elderly or frail patients with a newly diagnosed glioblastoma: A pooled analysis of patient-level data from 4 prospective trials. Cancer. PMID 35315512 DOI: 10.1002/cncr.34192  0.036
2020 Palmer JD, Sebastian NT, Chu J, DiCostanzo D, Bell EH, Grecula J, Arnett A, Blakaj DM, McGregor J, Elder JB, Lu L, Zoller W, Addington M, Lonser R, Chakravarti A, ... ... Raval R, et al. Single-Isocenter Multitarget Stereotactic Radiosurgery Is Safe and Effective in the Treatment of Multiple Brain Metastases. Advances in Radiation Oncology. 5: 70-76. PMID 32051892 DOI: 10.1016/J.Adro.2019.08.013  0.032
2021 Blakaj DM, Palmer JD, Dibs K, Olausson A, Bourekas EC, Boulter D, Ayan AS, Cochran E, Marras WS, Mageswaran P, Katzir M, Yildiz VO, Grecula J, Arnett A, Raval R, et al. Postoperative Stereotactic Body Radiotherapy for Spinal Metastasis and Predictors of Local Control. Neurosurgery. PMID 33575784 DOI: 10.1093/neuros/nyaa587  0.03
2023 Perlow HK, Nalin AP, Ritter AR, Addington M, Ward A, Liu M, Nappi C, Blakaj DM, Beyer SJ, Thomas EM, Grecula JC, Raval RR, Kotecha R, Boulter D, Dawson EL, et al. Advancing Beyond the Hippocampus to Preserve Cognition for Patients With Brain Metastases: Dosimetric Results From a Phase 2 Trial of Memory-Avoidance Whole Brain Radiation Therapy. Advances in Radiation Oncology. 9: 101337. PMID 38405310 DOI: 10.1016/j.adro.2023.101337  0.026
2023 Perlow HK, Nalin AP, Handley D, Gokun Y, Blakaj DM, Beyer SJ, Thomas EM, Raval RR, Boulter D, Kleefisch C, Bovi J, Chen WC, Braunstein SE, Raleigh DR, Knisely JPS, et al. A Prospective Registry Study of Ga-DOTATATE PET/CT Incorporation into Treatment Planning of Intracranial Meningiomas. International Journal of Radiation Oncology, Biology, Physics. PMID 37871886 DOI: 10.1016/j.ijrobp.2023.10.014  0.024
2022 Perlow HK, Yaney A, Yang M, Klamer B, Matsui J, Raval RR, Blakaj DM, Arnett A, Beyer S, Elder JB, Ammirati M, Lonser R, Hardesty D, Ong S, Giglio P, et al. Dose-escalated accelerated hypofractionation for elderly or frail patients with a newly diagnosed glioblastoma. Journal of Neuro-Oncology. PMID 35013838 DOI: 10.1007/s11060-021-03925-1  0.022
2019 Wolfe AR, Blakaj D, London N, Blakaj A, Klamer B, Pan J, Wakely P, Prevedello L, Bonomi M, Bhatt A, Raval R, Palmer J, Prevedello D, Gamez M, Carrau R. Erratum: Clinical Outcomes and Multidisciplinary Patterns of Failure for Olfactory Neuroblastoma: The Ohio State Experience. Journal of Neurological Surgery. Part B, Skull Base. 81: e1. PMID 37745951 DOI: 10.1055/s-0039-1694000  0.017
2020 Kander EM, Shah MH, Zhou Y, Goyal A, Palmer JD, Owen DH, Shilo K, Patel G, Raval RR, Gonzalez J, Nguyen M, Olek E, Kherani J, Rothenberg SM, Konda B. Response to the Selective RET Inhibitor Selpercatinib (LOXO-292) in a Patient With RET Fusion-positive Atypical Lung Carcinoid. Clinical Lung Cancer. PMID 32660930 DOI: 10.1016/j.cllc.2020.06.011  0.012
2022 Lu L, Yang X, Raterman B, Jiang X, Meineke M, Grecula J, Blakaj D, Palmer J, Raval R, Thomas E, Hintenlang D, Gupta N. Assessment of MRI image distortion based on 6 consecutive years of annual QAs and measurements on 14 MRI scanners used for radiation therapy. Journal of Applied Clinical Medical Physics. e13843. PMID 36385457 DOI: 10.1002/acm2.13843  0.011
Hide low-probability matches.